A Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel for the Improvement of Skin Quality in Adult Participants

Clinical trial NCT06151535 · COMPLETED

Trial details

NCT number: NCT06151535
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Skin Quality Deficit

Start date: 2023-12-19
Primary completion: 2025-02-24
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.